Dentsply Sirona Announces Appointment of Mr. John P. Groetelaars as New Board Member
06 Abril 2022 - 5:45PM
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:
XRAY) today announced that Mr. John P. Groetelaars has been
appointed to its Board of Directors (the “Board”), increasing the
size of its Board from eleven to twelve members.
“We are pleased to welcome John Groetelaars to the Dentsply
Sirona Board of Directors,” said Eric K. Brandt, Non-Executive
Chairman of the Board. “John brings more than 30 years of MedTech
experience with 20 years of international experience, including as
the former CEO of Hillrom. John’s deep medical technology
experience and leadership roles will be a valuable addition to our
Board of Directors. We look forward to working with him as we
continue to advance patient care through high-quality and
innovative dental solutions.“
Mr. John P. Groetelaars served as President, CEO and a Board
member at Hillrom from May 2018 until the company’s acquisition by
Baxter International, Inc., in December 2021. At Hillrom, he had
enterprise responsibility for a global healthcare technology
company with $3 billion in revenue and more than 10,000 employees.
Mr. Groetelaars led a transformation of Hillrom’s business,
successfully articulating and launching a new connected-care
strategy and vision, growing the portfolio through seven
acquisitions and one divestiture, and driving record financial
performance. In addition, he championed and actively led diversity,
inclusion, equity and belonging initiatives across the company,
which led to record levels of employee engagement, and external
recognition from DiversityInc, Forbes and many other organizations.
Prior to Hillrom, Mr. Groetelaars served as executive vice
president and president of the Interventional Segment at Becton,
Dickinson and Company, a medical technology company, since December
2017 following its acquisition of C.R. Bard Inc., a medical
technology company, where his responsibilities included global
strategic, financial, operational and innovation platforms. He
previously served in a variety of progressive roles at C.R. Bard
during his 10-year career there, including as a group president
from 2015 to 2017. Mr. Groetelaars joined C.R. Bard in 2008 as vice
president and general manager, Davol Inc., and was appointed
president of Davol in 2009. In 2013, Mr. Groetelaars was promoted
to group vice president and in 2015 he was promoted to group
president, a position he held until C.R. Bard was acquired by
Becton, Dickinson and Company in December 2017. Prior to joining
C.R. Bard, Mr. Groetelaars held various international leadership
positions in Canada, Denmark and the United Kingdom at Boston
Scientific Corporation from 2001 until 2008. Prior to joining
Boston Scientific, Mr. Groetelaars held positions in general
management, marketing, business development and sales with Guidant
Corporation and with Eli Lilly. He was also formerly a director on
the AdvaMed board.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of
professional dental products and technologies, with a 135-year
history of innovation and service to the dental industry and
patients worldwide. Dentsply Sirona develops, manufactures, and
markets a comprehensive solutions offering including dental and
oral health products as well as other consumable medical devices
under a strong portfolio of world class brands. As The Dental
Solutions Company, Dentsply Sirona’s products provide innovative,
high-quality and effective solutions to advance patient care and
deliver better, safer and faster dentistry. The Company’s shares of
common stock are listed in the United States on Nasdaq under the
symbol XRAY. Visit www.dentsplysirona.com for more information
about Dentsply Sirona and its products.
Contact Information
Investors:Andrea DaleyVP, Investor
Relations+1-704-805-1293InvestorRelations@dentsplysirona.com
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024